相关实验视频
Updated: Jul 26, 2026

09:16
Assessment of Kidney Function in Mouse Models of Glomerular Disease
Published on: June 30, 2018
17.7K
淋巴细胞转录学可以预测长期结果,并为假定良性IgA脏病患者确定治疗策略
Mariell Rivedal1, Håvard Mikkelsen1, Hans-Peter Marti2
1Department of Clinical Medicine, University of Bergen, Bergen, Norway.
Kidney international
|December 28, 2023
概括
活检中的基因表达可以在临床诊断前几年预测IgA病 (IgAN) 的进展. 这一发现为在看似良性IgAN.患者早期干预提供了新的希望.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- IgA 病 (IgAN) 可以有不可预测的渐进过程.
- 目前的临床和组织病理学参数不能可靠地预测所有患者的Igan进展.
研究的目的:
- 为了确定质细胞中的基因表达是否可以区分IGAN进展者和非进展者.
- 为了确定与IGAN疾病进展相关的特定基因.
主要方法:
- 来自Igan患者的档案脏活检中的微切片质细胞被分析用于基因表达.
- 一个由两部分组成的分类器被用来识别进发性和非进发性基因.
- 验证使用免疫组织化学和nCounter技术进行.
主要成果:
- 确定了一组八个IgAN进展基因和九个非进展基因.
- 这些基因在临床文档之前平均在21年内以高准确度 (88%),灵敏度 (75%) 和特异性 (100%) 预测疾病进展.
- APOL5和ZXDC是已确定的预测基因之一.
结论:
- 诊断时的淋巴细胞mRNA测序可以识别未来的IgAN进展者.
- 这种方法可以在潜在的渐进性和稳定的IgA脏病患者之间进行早期区分.
- 这些发现可能会导致IGAN的早期治疗干预.
相关概念视频
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...

